Simulations Plus, Inc. Stock News
$28.77
3.16%
yesterday
Nasdaq,
Nov 15, 10:00 pm CET
Simulations Plus, Inc. Stock News
Neutral
Business Wire
●
3 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, in partnership with the University of Connecticut, was awarded a new FDA grant to investigate additional LAI product technologies.
Neutral
Business Wire
●
10 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Shawn O'Connor, CEO, will participate in a fireside chat at the Stephens Annual Investment Conference on Wednesday, November 20, 2024 at 12:00pm ET.
Neutral
Business Wire
●
17 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, with industry and academic partners, was awarded a new FDA grant to validate new methods for more efficient drug development.
Neutral
Seeking Alpha
●
23 days ago
Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript
Neutral
Business Wire
●
23 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported fiscal year 2024 total revenues of $70 million, 18% over fiscal 2023, and 4th quarter total revenues of $18.7 million.
Neutral
Business Wire
●
about one month ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will host a conference call & webcast on October 23, 2024, at 5pm ET to discuss 4th quarter & fiscal year 2024 financial results.
Neutral
Business Wire
●
about one month ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, in partnership with USC, is awarded a new research grant from the NIH to develop new AI-driven Drug Design methods.
Neutral
Business Wire
●
3 months ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Morgan Stanley's Global Healthcare Conference on September 6, 2024, in New York City.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
